Hearing: PCBs Alter Brain Development by Burton, Adrian
Sanity remains defined simply by the ability to cope
with insane conditions.
Ana Castillo
Massacre of the Dreamers (1994) 
Environews Forum
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PCBs Alter Brain
Development
Exposure to the non-coplanar polychlori-
nated biphenyl PCB95 during gestation
and nursing causes abnormal development
of the auditory cortex in rats, affecting the
brain’s representation of what is heard,
according to new research in the 1 May 2007
issue of Proceedings of the National Academy
of Sciences. Since children with autism and
other developmental disorders show abnor-
mal responses to sound, suspicions have been
raised that PCB95 and similar molecules in
the environment might promote this prob-
lem and perhaps other language/cognition
disorders in children.
Prior to their being banned in the late
1970s as potential carcinogens, PCBs
became ubiquitous environmental pollu-
tants that continue to threaten human
health. Their molecular stability has main-
tained them intact, and they have entered
the food chain, accumulating in the fat of
exposed organisms.
Most of the early work on PCB-
associated health problems focused on the
coplanar molecules, but there is now evi-
dence that non-coplanar PCBs may cause
trouble of their own (coplanar and non-
coplanar refer to the chemical structure of
the PCBs in question). “They are reported
to prevent dopamine production in monkey
brains, to alter behavior in rats, and may
even alter neuropsychological functioning in
children,” explains first author Tal Kenet, a
faculty member at Harvard Medical School
and Massachusetts General Hospital. “Our
research suggests they cause abnormalities
in the development of the auditory part of
the rat brain.”
The researchers fed pregnant rats
6 mg/kg of PCB95 in corn oil daily from
day 5 of pregnancy until the weaning of
their pups. “We then mapped the boundary
and response characteristics of the primary
auditory cortex of the pups using a series of
electrodes implanted in the brain,” says
Kenet. “Individual neurons were monitored
to see which characteristic sound frequency
they responded to.” The auditory cortex is
one of the first sensory systems to mature.
The maps of the PCB95-exposed rats
were found to be oddly shaped and had
“holes” in them where neurons seemed not
to respond to sound. The maps also includ-
ed many neurons that showed a lack of fre-
quency selectivity, and the typical posterior-
to-anterior distribution of neurons
responding to ever higher frequencies was
disorganized.
“This must affect how their brains inter-
pret sound,” says Kenet. “In addition, we
recorded notable imbalances in inhibitory
and excitatory signaling between the audito-
ry cortex nerve cells. Without proper bal-
ancing, the correct representation of sound
cannot be guaranteed. Importantly, children
with autism show evidence of imbalances
between excitation and inhibition in the
brain, but whether it’s the same type of
imbalance remains to be explored.”
The researchers also found the plasticity
of the PCB-exposed cortices to be abnormal.
Usually, if rat pups are exposed to a particu-
lar tone, the area of the cortex that deals with
that frequency expands. “That did not hap-
pen in the PCB-exposed pups,” says Kenet. 
“Epidemiological studies have found
that children with prenatal PCB exposure do
more poorly on tests of verbal learning and
memory,” says Susan Schantz, a professor of
veterinary biosciences at the University of
Illinois at Urbana–Champaign College of
Veterinary Medicine. “These exciting new
findings suggest that underlying changes in
the development or plasticity of the audito-
ry cortex may be responsible for those
effects.” However, Schantz cautions that the
rats in these studies received a very high dose
of a very potent PCB congener. “In my
opinion,” she says, “it is unlikely that human
infants, even those living in highly polluted
areas, would be exposed to similar concen-
trations. We also need to keep in mind that
any effects observed in humans are likely to
be much more subtle than the striking
changes observed in these rats.”
“It would be interesting to know
whether animals closer to humans develop
disorders resembling autism or other cogni-
tive problems after [environmentally rele-
vant] PCB95 exposures,” remarks Jesús
Pastor, a senior researcher at the Centre for
Environmental Sciences in Madrid, Spain.
“That might help reveal how serious this
problem could be.” 
Since PCBs can be passed on to human
infants in breast milk, the report raises the
question of whether some mothers in high-
ly polluted areas—perhaps those whose
family history points toward a possible
genetic risk of autism spectrum disorders—
should bottle-feed rather than breastfeed.
However, “some research shows that breast-
feeding may actually lessen the negative
impact of prenatal exposure, even though
children who are breastfed have higher over-
all body burdens of PCBs,” says Schantz.
–Adrian Burton
HEARING
Top left shows a tonotopic map of the primary auditory cortex of a normal rat pup. At the left end
of the map are neurons that are selective for low-frequency tones (blues); at the other end are neu-
rons that respond only to high-frequency tones (reds). This pattern is usually smooth (i.e., no holes),
continuous (gradually changing from one end to the other), and elliptical in shape. The other three
examples above are from rats exposed to PCB95. These maps are neither continuous nor smooth,
are very disorganized, and have erratic shapes.
Source: Kenet T et al. 2007. Perinatal exposure to a noncoplanar polychlorinated biphenyl alters tonotopy, receptive fields, and plas-
ticity in rat primary auditory cortex. Proc Natl Acad Sci USA 104(18):7646–7651. Indian Subcontinent Gets
Environmental Monitoring
Members of an Indo-U.S. workshop report in the
13 April 2007 issue of Science that to understand and
slow global environmental change, there needs to be
a global network of environmental data collection.
Currently, much of Africa and the Indian subcontinent
lacks such a network, although these areas have
considerable influence on the regional and global
environment. To help alleviate this information
shortage, the Indian government is developing a new
monitoring network known as INDOFLUX. This
network will generate the needed baseline data from
which to evaluate future environmental changes in a
country where much of the population depends on
natural resources and coastal integrity.  
Manufacturing Energy Use:
Room for Improvement
The U.S. EPA has released a report that outlines energy
use trends in 12 manufacturing sectors representing
about 85% of total industrial energy use in the
country. Energy Trends in Selected Manufacturing
Sectors shows that industry has significant
opportunities for improving its environmental
performance through adopting energy-efficient and
clean-energy technologies. The report also projects
that with a “business-as-usual” scenario, total energy
consumption of the sectors studied could increase by
20% over 2004 levels in the next 13 years, and that
CO2 emissions could increase by 14%. The EPA further
determined that use of renewable fuels in industry is
now higher than in the residential, commercial, and
transportation sectors, and is growing.
California Rules on
Formaldehyde
Citing studies on throat cancer, workplace asthma,
and increased asthma and allergies in children, the
California Air Resources Board has adopted new
restrictions on formaldehyde that will cut by nearly
60% the amount of the chemical emitted into air
from the resins and glues used to bond plywood,
particleboard, and medium-density fiberboard. The
total amount of formaldehyde emitted into
California’s air each year will be reduced from the
current 650 tons to 150 tons. The new rule will be
phased in beginning in 2009, with full implementation
in 2012. It will apply to all products sold, used, or
made for sale in the state. Manufacturers will need to
obtain third-party certification, maintain records, and
label all wood or wood products to show compliance
with the law.
GINA Passes in House
The Genetic Information Nondiscrimination Act
(GINA), first introduced in the House 12 years ago, was
finally approved by that chamber in April 2007. GINA
prohibits the wrongful use of genetic information in
the making of hiring and health insurance decisions.
Genetic factors are linked to 15% of all cancers and
10% of adult chronic diseases such as heart disease
and diabetes. More than 200 organizations from
different sectors have endorsed GINA, which had
bipartisan support in the House with more than 200
cosponsors. The bill now goes to the Senate, which has
passed it twice in recent years. President Bush has
already voiced his support for the legislation. 
Forum
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Dementia and
Secondhand Smoke
Secondhand smoke is known to be associat-
ed with cardiovascular disease, which in
turn is a known risk factor for dementia, but
little research has examined the latter end
point with regard to secondhand smoke.
Research presented at the 28 April–5 May
2007 annual meeting of the American
Academy of Neurology now suggests that
increased risk of Alzheimer disease and
other forms of dementia may well belong on
the long list of potential health effects from
chronic exposure to secondhand smoke.
“When we started this study, . . . we
knew of the likely pathway through cardio-
vascular disease, but we were also interested
in an independent pathway from second-
hand smoke [directly] to dementia,” says
principal investigator Thaddeus Haight, a
senior statistician at the University of
California, Berkeley. That direct pathway did
not bear out, but the team did make a new
discovery regarding the cardiovascular link.
Haight and his colleagues analyzed
health data for elders with and without
cardiovascular disease that had been col-
lected through the Cardiovascular Health
Study, a national study of cardiovascular
disease risk factors in adults older than 65.
Of the 3,602 participants who had been
evaluated for dementia, 985 had no histo-
ry of cardiovascular disease or symptoms of
dementia and had never smoked, and 495
reported an average of nearly 28 years of
secondhand smoke exposure.
The group most highly exposed to second-
hand smoke—those with a lifetime expo-
sure of more than 30 years—had a 30%
greater risk for developing dementia com-
pared with the no-exposure group. Within
the highly exposed group, people with
subclinical cardiovascular disease (defined
as narrowing of the carotid artery) had an
even higher risk, nearly 2.5 times that of
the no-exposure group. “There weren’t
really any independent effects due to sec-
ondhand smoke exposure alone, but there
were effects through a pathway other than
clinical cardiovascular disease,” says Haight.
“In people with indications of subclinical
disease, . . . the greater the exposure to sec-
ondhand smoke, the more elevated the
risk of dementia.”
“These results are definitely not sur-
prising; they are completely in line with
what we know about heart health and
brain health—that both are extremely
interconnected,” says Maria Carrillo,
director of medical and scientific relations
for the Alzheimer’s Association national
office. “Anything that makes it more diffi-
cult for your heart to pump blood
through your body will ultimately affect
how your body pumps blood into the
brain. That compromised brain blood vol-
ume really makes a difference after years of
exposure.”
Haight and his colleagues are currently
working to confirm their findings. He
says, “What would be interesting from this
work that we’ve done so far is to extend it
to look at the risk of dementia in those
with a history of secondhand smoke expo-
sure who have diabetes or hypertension.”
–Julia R. Barrett
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Sunny Side of
Cancer Prevention
Many studies have linked higher latitudes
with greater breast cancer risk, and seasonal
variations are now thought to influence can-
cer incidence and mortality. The pivotal
mediators in these relationships are believed
to be sunshine and vitamin D. In clinical
studies, poor vitamin D status is associated
with a substantial increase in breast cancer
incidence and mortality, though until recent-
ly, there has been only limited evidence in
humans that vitamin D–related factors may
reduce breast cancer risk. New studies are
now clarifying the role of this nutrient. 
For most people, sunshine is the main
source of vitamin D and specifically of
25(OH)D. Vitamin D is unusual among
nutrients because very few foods naturally
contain it, and supplementation is intended
primarily to compensate for a deficiency of
sunshine. Most human photosynthesis occurs
in the summer, because the angle of sunlight
largely determines the rate of vitamin D syn-
thesis. Among the better-defined mechanisms
of vitamin D’s anticancer action are its abil-
ity to induce cell differentiation and apopto-
sis of cancer cells while also inhibiting cell
proliferation, angiogenesis, and metastasis.
In the March 2007 issue of Cancer Epi-
demiology Biomarkers & Prevention, authors
from Mount Sinai Hospital in Toronto
described a case–control study involving 972
women with newly diagnosed invasive breast
cancer and 1,135 healthy controls. All par-
ticipants were interviewed to assess vitamin
D–related exposures, such as outdoor activi-
ties, sun exposure habits (e.g., use of sun-
screen), and dietary contributions (cod liver
oil and milk consumption). More frequent
sun exposure during adolescence was associ-
ated with a 35% reduction in breast cancer
risk later in life. Lower risk was also linked to
cod liver oil intake and drinking at least 10
glasses of milk per week. Milder protection
was seen for people aged 20 to 29, but not
for people over age 45. 
“Our study suggests that vitamin D–
related exposures during adolescence and early
adulthood, when the breasts are developing,
may be more important than later exposure,”
says lead author Julia Knight, a senior investi-
gator at Toronto’s Prosserman Centre for
Health Research. “A study in postmenopausal
women asking about recent diet or sun would
miss an effect of earlier exposure.” 
Knight is also interested in knowing
what effect sunlight supplementation may
have in women following treatment for
breast cancer. An epidemiologic study of dif-
ferent regions of Norway, each with a differ-
ent annual UV exposure, found that the
prognosis was 15–25% better for women
diagnosed (and thus treated) in the summer
versus the winter. This research was pub-
lished in the May 2007 issue of Breast Cancer
Research and Treatment. 
A second study out of Laval University
in Quebec sought to assess seasonal varia-
tions of breast density, a biomarker of breast
cancer risk. The goal was to compare such
variation, if any, with blood levels of
25(OH)D. It was assumed that a delay or lag
time might be likely between a change in
25(OH)D levels and the resulting change
in breast density. The researchers recruited
741 premenopausal women at screening
mammography and found a strong inverse
correlation between mammographic breast
density and circulating vitamin D levels.
When a four-month lag time was assumed,
seasonal variations of breast density and cir-
culating vitamin D appeared to be highly
What Is Radiation’s True Target?
Radiobiologists have long believed that ionizing radiation, like gamma
rays, kills cells by shattering DNA. Now Michael Daly, an associate
professor of pathology at the Uniformed Services University of the
Health Sciences, contends that proteins—not DNA—are the most
sensitive targets, at least in some radiation-sensitive bacteria. Moreover,
Daly’s team discovered a novel manganese complex that appears to
protect proteins from gamma rays. This new perspective comes from
working with Deinococcus radiodurans, a bacterium nicknamed
“Conan the Bacterium” because it survives huge radiation doses. 
For 15 years, Daly probed DNA,
genes, and chromosomal packaging for
clues to how Deinococcus defies death.
He noticed that Deinococcus and other
radiation-resistant bacteria accumulated
high levels of manganese, compared
with radiation-sensitive bacteria. When
zapped with the same dose of gamma
rays, however, radiation-resistant and
radiation-sensitive bacteria all experi-
enced about the same number of dou-
ble-strand DNA breaks. Daly reported
these results in the 5 November 2004
Science, then tackled the remaining ques-
tion: What does manganese protect in
radiation-resistant bacteria? 
The latest proof-of-concept experi-
ments, published in the April 2007 PLoS
Biology, showed that manganese neutral-
ized reactive oxygen species (ROS),
or free radicals, generated by ionizing radiation. When the researchers
bombarded radiation-resistant bacteria with gamma rays, manganese
appeared to protect proteins from a form of oxidative damage called
carbonylation. But in radiation-sensitive bacteria with little man-
ganese, gamma rays caused high levels of protein oxidation, and the
microbes died. Shifting the emphasis from DNA to proteins “is
heretical,” Daly admits, “but the data speak for themselves.” 
Daly’s surprising results “fly in the face of fifty years of dogma,”
says John Battista, a professor of microbiology at Louisiana State
University. Gamma rays cause a variety of DNA lesions, and Daly
measured only double-strand breaks, one of the least abundant types.
“I would be more convinced if he measured a more abundant lesion
like thymine glycol levels,” says Battista.
Daly’s laboratory has most recently
identified a small manganese complex
in Deinococcus that is extremely resistant
to ionizing radiation and protects pro-
teins but not DNA. Daly plans to pur-
sue practical applications for the
manganese complex in mammalian
cells, such as protecting people against
radiation sickness, or sparing healthy
cells from the ravages of radiation dur-
ing cancer treatment. Many toxicants—
including tobacco smoke, ultraviolet
light, and heavy metals—damage cells
via the production of ROS. If the com-
plex prevents ROS damage to proteins
in mammalian cells, too, other applica-
tions might someday include a lotion
that could protect skin from ultraviolet
rays. “All this lies ahead to be proven,”
Daly says. –Carol Potera
MOLECULAR BIOLOGY
DIET AND NUTRTION
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2007 Goldman Environmental Prize
On 23 April 2007, the 2007 Goldman Environmental Prize
was awarded in San Francisco to grassroots activists from
around the world to honor their work in protecting the
environment of their communities. This year’s winners 
are (above, clockwise from top left) 
• Sophia Rabliauskas of Canada, who secured interim
protection for the boreal forest of Manitoba against
logging and hydropower development while the area’s
future is decided by the government and international
agencies.
• Hammerskjoeld Simwinga of Zambia, who developed
an innovative sustainable community development
program that protects biodiversity and helps alleviate
poverty.
• Tsetsegee Munkhbayar of Mongolia, who worked
with government and grassroots organizations to halt
unregulated mining operations that threatened the
country’s scarce water resources.
• Julio Cusurichi of Peru, who gained protection for an
area of the remote Peruvian Amazon against logging
and mining, preserving a sensitive ecosystem and the
rights of indigenous peoples.
• Willie Corduff of Ireland, who headed a group of
activists and landowners in successfully halting the
construction of an illegally approved petroleum pipeline.
• Orri Vigfússuon of Iceland, who negotiated an
agreement with governments and corporations to end
destructive commercial salmon fishing practices in the
region.
NARSAD: The Mental Health Research Association ehpnet
In the early 1980s, three leading national mental health groups came
together to form the American Schizophrenia Association. Since that time
the organization has evolved in both name and scope; it is now known as
NARSAD: The Mental Health Research Association to reflect its current
focus on a wide range of mental disorders. NARSAD works not only to fund
research to prevent, diagnose, and treat psychiatric diseases, but also to
educate the public about these conditions. Visitors can find information on
these initiatives and more at http://www.narsad.org/.
The Diseases and Conditions section of the NARSAD site is divided into
six main sections: schizophrenia, depression, bipolar disorder, anxiety, child-
hood disorders, and other disorders. Each section offers a brief overview of
the illness on which it focuses and a summary of symptoms and treatments.
Insight into NARSAD’s research into the illness is also available. In addition,
feature stories on related topics are provided, as is information for people
recently diagnosed with the illness, including resources for learning about
the illness they have been diagnosed with and the medications they have
been prescribed.
The Research Center portion of the NARSAD site provides information
for potential grant recipients on how to apply for funding, provides a list
of grantees, and notifies visitors of NARSAD grant deadlines. A section of
project summaries gives visitors a look at the work NARSAD supports.
Among other projects are a twin study to tease out the nongenetic family
background contributions to depression and a mouse study of how
changes in maternal behavior associated with a genetic modification may
be passed to offspring that do not possess the modification. –Erin E. Dooley
synchronized, so much so that “variations of
breast density appeared to be a mirror image
of those of 25(OH)D,” the researchers wrote
in the May 2007 issue of Cancer Epidemi-
ology Biomarkers & Prevention. 
“Taking seasonal variations and lag time
into account appears to be crucial when
studying the relation of circulating vitamin
D to breast density,” says lead author Jacques
Brisson, a professor in the Department of
Social and Preventive Medicine at Laval
University. “These time-related variables
may also be crucial when studying the effect
of vitamin D supplementation, because the
latter is likely to vary with time, typically
being more pronounced in fall and winter,
for example.” 
Brisson and Knight agree that the next
step is to carry out randomized trials of the
effect of vitamin D supplementation, as only
this type of design would establish causality
between high vitamin D intake and reduc-
tion in breast cancer risk. A randomized con-
trolled study published in the June 2007
issue of the American Journal of Clinical
Nutrition found that women who regularly
took vitamin D3 and calcium had a 60%
reduction in all-cancer incidence compared
with a group taking placebos and a 77%
reduction when the analysis was confined to
cancers diagnosed after the first 12 months.
Observational studies such as those spear-
headed by Brisson and Knight have suggest-
ed a less dramatic reduction in cancer risk
(50% or more). 
Public health officials agree that limiting
sun exposure will reduce the rate of skin can-
cers, but some scientists worry that such
advice may lead to undesirable tradeoffs on a
massive scale. “There are at most one or two
extra skin cancer deaths [per hundred thou-
sand people] when you compare the north-
ern to southern United States . . . versus
about thirty or forty fewer deaths for the
other major cancers,” says Reinhold Vieth,
an associate professor of nutrition at the
University of Toronto. “So if you tally up the
number of deaths likely to be attributable to
UV light or vitamin D, it does not look like
the most sensible policy to tell people to keep
out of the sun just to prevent skin cancer.”
Vieth’s advice is for white people to expose
more skin for a shorter time, for example by
lying in a bathing suit for 10 minutes on
each side, twice per week, and over 4 to 8
weeks of summer. Darker-skinned people
should stay in the sun longer or take vitamin
D supplements. –M. Nathaniel Mead
G
o
l
d
m
a
n
 
E
n
v
i
r
o
n
m
e
n
t
a
l
 
P
r
i
z
e